Results 41 to 50 of about 1,896 (179)

Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

open access: yesBulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi   +11 more
doaj   +1 more source

Malaria chemoprevention and drug resistance: a review of the literature and policy implications

open access: yesMalaria Journal, 2022
Chemoprevention strategies reduce malaria disease and death, but the efficacy of anti-malarial drugs used for chemoprevention is perennially threatened by drug resistance.
Christopher V. Plowe
doaj   +1 more source

Shifts in the clinical epidemiology of severe malaria after scaling up control strategies in Mali

open access: yesFrontiers in Neurology, 2022
A decrease in malaria incidence following implementation of control strategies such as use of artemisinin-based combination therapies, insecticide-impregnated nets, intermittent preventive treatment during pregnancy and seasonal malaria chemoprevention ...
Drissa Coulibaly   +14 more
doaj   +1 more source

Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial. [PDF]

open access: goldBMJ Open
Moreno M   +22 more
europepmc   +3 more sources

Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention [PDF]

open access: yesNew England Journal of Medicine, 2019
Mass administration of azithromycin for trachoma control led to a sustained reduction in all-cause mortality among Ethiopian children. Whether the addition of azithromycin to the monthly sulfadoxine-pyrimethamine plus amodiaquine used for seasonal malaria chemoprevention could reduce mortality and morbidity among African children was unclear.We ...
Ismaila Thera   +18 more
openaire   +3 more sources

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon. [PDF]

open access: goldWellcome Open Res
Tchuenkam PVK   +14 more
europepmc   +2 more sources

Seasonal Malaria Chemoprevention Coverage in Guinea in 2019 [PDF]

open access: yes, 2020
SMC involves the administration of a treatment course of sulfadoxine-pyrimethamine plus amodiaquine once a month to children aged 3 59 months during the high risk period each year to prevent malaria. SMC over 4 months of the year was introduced in Guinea in 2015 in 6 prefectures, scaling up to 13 prefectures by 2018.
Loua, Kovana Marcel, Milligan, Paul
openaire   +2 more sources

Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria [PDF]

open access: yesBMJ Global Health, 2022
BackgroundIn 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical trials have found SMC to prevent around 75% of clinical malaria.
Monica Anna de Cola   +12 more
openaire   +5 more sources

Combining malaria vaccination with chemoprevention: a promising new approach to malaria control

open access: yesMalaria Journal, 2021
Malaria control has stalled in a number of African countries and novel approaches to malaria control are needed for these areas. The encouraging results of a recent trial conducted in young children in Burkina Faso and Mali in which a combination of the ...
Brian Greenwood   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy